Discontinued — last reported Q2 '25
Merck & Co. Components decreased by 0.3% to $292.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.5%, from $309.00M to $292.00M. Over 5 years (FY 2020 to FY 2025), Components shows an upward trend with a 11.6% CAGR.
Changes in components provide insight into the shifting nature of the underlying asset or liability class.
This is a generic placeholder used to categorize or aggregate specific sub-items within a financial statement line item....
Varies significantly based on specific accounting disclosures.
components| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $244.00M | $229.00M | $234.00M | $248.00M | $254.00M | $255.00M | $289.00M | $287.00M | $287.00M | $296.00M | $299.00M | $297.00M | $355.00M | $302.00M | $309.00M | $309.00M | $307.00M | $293.00M | $292.00M |
| QoQ Change | — | -6.1% | +2.2% | +6.0% | +2.4% | +0.4% | +13.3% | -0.7% | +0.0% | +3.1% | +1.0% | -0.7% | +19.5% | -14.9% | +2.3% | +0.0% | -0.6% | -4.6% | -0.3% |
| YoY Change | — | — | — | — | +4.1% | +11.4% | +23.5% | +15.7% | +13.0% | +16.1% | +3.5% | +3.5% | +23.7% | +2.0% | +3.3% | +4.0% | -13.5% | -3.0% | -5.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.